CPR-1006

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCPR-1006
Drug Alias Namepsoriasis inhibitors (Clarion)CPR-1006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transduction pathway inhibitorsPhospholipase C inhibitorsProtein kinase C inhibitors
TargetsPhospholipase CProtein kinase C
Therapy Area/IndicationsPsoriasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesClarion Pharmaceutical Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClarion Pharmaceutical Co
Active IndicationsN/A
Inactive IndicationsPsoriasisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A